Addition of receptor tyrosine kinase inhibitor to radiation increases tumour control in an orthotopic murine model of breast cancer metastasis in bone

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Pawel ZwolakArkadiusz Z Dudek

Abstract

The receptor tyrosine kinase inhibitor, SU11248, was added to localised radiation to evaluate the response of bone metastases and to define the basic mechanism of radiosensitisation. Treatment with SU11248 and radiation was assessed in vitro using cultured 4T1 breast cancer cells and in vivo using an orthotopic 4T1 murine mammary tumour model of breast cancer bone metastasis. Cultured 4T1 cells treated with SU11248 (1 microM) and radiation (10 Gy) showed an almost 7.5-fold increase in caspase-mediated apoptosis after 24 h of incubation, compared to either treatment alone. Mice treated with SU11248 (40 mg/kg/daily) and radiation (15 Gy/single-dose) had a relatively greater reduction in tumour growth, bone osteolysis, osteoclast maturation and microvessel density. Combined modality treatment resulted in improvements in behavioural pain assessment scores and normalisation of neurochemical changes in the spinal cord receiving primary afferent innervation from tumour-bearing femora. Our study demonstrates that SU11248 enhances the radiation control of metastatic breast tumours in bone and tumour-induced pain.

References

Apr 1, 1998·Journal of the National Cancer Institute·J YonedaI J Fidler
Jul 4, 2001·Drugs·C Ripamonti, E D Dickerson
Jan 1, 1997·Apoptosis : an International Journal on Programmed Cell Death·K D Held
Jan 10, 2004·Clinical & Experimental Metastasis·Lesley J MurrayNancy K Pryer
Jan 21, 2004·Radiation Research·M GoblirschD R Clohisy
Feb 18, 2004·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Jie PanErnest Cutz
Jun 16, 2004·Cancer Metastasis Reviews·In Ah KimEric J Bernhard
Jun 21, 2005·Pain·Tamara KingFrank Porreca
Sep 9, 2005·Journal of Cellular Biochemistry·M J GoblirschD R Clohisy
May 19, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael GoblirschDenis R Clohisy
Sep 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dan G DudaChristopher G Willett
Oct 19, 2007·International Journal of Cancer. Journal International Du Cancer·Pawel ZwolakDenis R Clohisy

❮ Previous
Next ❯

Citations

Apr 19, 2012·Biological Procedures Online·Celeste BolinCheryl L Jorcyk
Dec 12, 2013·Breast Cancer Research and Treatment·Dareen M AbdelazizSvetlana V Komarova
Nov 13, 2013·Microvascular Research·Ahmed El KaffasGregory J Czarnota
Aug 24, 2010·Leukemia Research·Domenico Ribatti
Jan 12, 2010·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Amir Abdollahi, Judah Folkman
Mar 10, 2011·International Journal of Cancer. Journal International Du Cancer·Shinya MaitaTomonori Habuchi
Jul 24, 2015·Angiogenesis·Esther A KleibeukerVictor L Thijssen
Jun 30, 2015·Journal of Veterinary Internal Medicine·J H BurtonD H Thamm
May 7, 2014·International Journal of Cancer. Journal International Du Cancer·Leandro E MainettiR Daniel Bonfil
Nov 19, 2015·Journal of Bone Oncology·Aude I SégalinyDominique Heymann
Aug 19, 2011·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Hui WangJintian Tang
Feb 15, 2015·Pharmacology & Therapeutics·Rachelle W JohnsonAmato J Giaccia
Jun 16, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul J KellyToni K Choueiri
Jun 27, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Kenta NakaoToshiaki Minami

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis